GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Diamond Biofund Inc (TPE:6901) » Definitions » YoY EBITDA Growth

Diamond Biofund (TPE:6901) YoY EBITDA Growth : 29.83% (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Diamond Biofund YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Diamond Biofund's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 29.83%.

Diamond Biofund's EBITDA per Share for the three months ended in Mar. 2025 was NT$-0.66.

Diamond Biofund YoY EBITDA Growth Historical Data

The historical data trend for Diamond Biofund's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamond Biofund YoY EBITDA Growth Chart

Diamond Biofund Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial 7,771.25 -49.26 -62.75 -384.83 15.86

Diamond Biofund Quarterly Data
Dec19 Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,843.75 92.18 45.03 -421.98 29.83

Diamond Biofund YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Diamond Biofund's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-2.78--3.304)/ | -3.304 |
=15.86 %

Diamond Biofund's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(-0.661--0.942)/ | -0.942 |
=29.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamond Biofund YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Diamond Biofund's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Diamond Biofund Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Diamond Biofund Inc (TPE:6901) » Definitions » YoY EBITDA Growth
Comparable Companies
ROCO:7777 BLK BX KKR OSTO:INVE A TSX:BAM TSX:BN APO LSE:III AMP XSWX:PGHN ARES OSTO:EQT RJF STT TSX:PHYS.U TROW XAMS:CVC BOM:543940 LSE:LGEN
Traded in Other Exchanges
N/A
Address
No. 236, Section 4, Xinyi Road,, 11th Floor, Daan District, Taipei City, TWN, 106047
Website
https://www.diamondbiofund.com
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting global and internationally competitive investment targets, including new drug research and development, high-end medical equipment, innovative medical service technology, medical access, agricultural biotechnology.

Diamond Biofund Headlines

No Headlines